A Deep Dive into the Next Generation Sequencing Market Landscape

A Deep Dive into the Next Generation Sequencing Market Landscape


Dec 7, 2023

Blog Biotechnology A Deep Dive into the Next Generation Sequencing Market Landscape

In the ever-evolving landscape of genomics and biotechnology, Next Generation Sequencing (NGS) has emerged as a transformative force. The NGS market has witnessed rapid growth in recent years, unlocking new possibilities in fields like healthcare, agriculture, and personalized medicine. This blog will explore the current state of the Next Generation Sequencing Market, shedding light on trends, applications, and the impact it has had on various industries.

The Basics of Next Generation Sequencing

Before we delve into the market dynamics, let's understand the basics of NGS. Next Generation Sequencing, also known as high-throughput sequencing, is a revolutionary technology that enables the rapid and cost-effective sequencing of DNA and RNA. It has replaced traditional Sanger sequencing and has brought genomics to the forefront of research and diagnostics.

Next Generation Sequencing Market Size and Growth

The NGS market has seen impressive growth over the past decade. According to BCC Research, The global Next-Generation Sequencing (NGS) market for drug development is projected to achieve a value of $2.9 billion by 2028, experiencing a substantial compound annual growth rate (CAGR) of 17.7% from the baseline of $1.3 billion in 2023 during the forecast period spanning from 2023 to 2028.

Key Market Trends

  1. Clinical Applications: NGS is increasingly being adopted in clinical settings. It plays a crucial role in diagnosing genetic disorders, monitoring cancer progression, and providing personalized treatment options.
  2. Agrigenomics: Agriculture is benefiting from NGS as well. It is used to improve crop yields, develop disease-resistant plants, and enhance breeding programs.
  3. Pharmaceutical Research: In drug discovery and development, NGS is accelerating the identification of potential drug targets and understanding disease mechanisms, leading to more efficient drug development processes.
  4. Direct-to-Consumer Testing: The rise of direct-to-consumer genetic testing services, such as 23andMe and AncestryDNA, has created a consumer market for NGS, making genetic information accessible to the general public.
  5. Technological Advancements: The NGS market is driven by ongoing technological advancements. Innovations in sequencing platforms, data analysis, and automation are making NGS more efficient and cost-effective.

Global Next-Generation Sequencing on Drug Development Market

The global next-generation sequencing (NGS) market in drug development should reach $2.9 billion by 2028 from $1.3 billion in 2023 at a compound annual growth rate (CAGR) of 17.7% for the forecast period of 2023 to 2028.

Key Players in Next Generation Sequencing Market

  1. Illumina, Inc.: A pioneer in NGS technology, Illumina is a leading provider of sequencing platforms and associated consumables.
  2. Thermo Fisher Scientific, Inc.: Thermo Fisher offers a range of products and services in the life sciences, including NGS solutions through its Ion Torrent platform.
  3. Roche Holding AG (through its subsidiary, Roche Sequencing Solutions): Roche is involved in the development of NGS technologies and associated products.
  4. Pacific Biosciences of California, Inc. (PacBio): PacBio is known for its single-molecule, real-time (SMRT) sequencing technology.
  5. BGI Genomics: BGI is a Chinese genomics company that provides sequencing services and develops NGS technologies.

Challenges and Opportunities

While the NGS market offers immense opportunities, it also faces challenges. These include data analysis complexities, ethical concerns, and data privacy issues. However, these challenges have spurred the growth of bioinformatics and data analysis companies.

As for opportunities, the NGS market is poised for further expansion in clinical diagnostics, cancer genomics, and non-invasive prenatal testing. The market's potential is far-reaching, and its impact on precision medicine, agriculture, and basic research cannot be understated.


The Next Generation Sequencing market is a dynamic and transformative force in the world of genomics and beyond. As technology evolves, its applications will expand, making it a crucial tool for research, healthcare, and industry. It is an exciting time for NGS and staying informed about the latest trends and innovations is vital for those involved in this ever-expanding field. BCC Research will keep a close eye on the NGS market as it continues to shape the future of science and medicine.

Learn More and Take Action:

Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.

Contact us today to find out more.

    Stay ahead of industry trends, build your market research strategy and more.

    Adarsh Rawat

    Written By Adarsh Rawat

    I am Adarsh Rawat and I have a degree in BBA from Jamia Milia Islamia, I have honed a diverse skill set that spans digital marketing, traditional advertising, brand management, and market research. My journey in marketing has been characterized by a commitment to innovation and an ability to adapt to emerging trends.

    Guiding smart decisions every step of the way

    Guiding smart decisions every step of the way

    We are your trusted research partner, providing actionable insights and custom consulting across life sciences, advanced materials, and technology. Allow BCC Research to nurture your smartest business decisions today, tomorrow, and beyond.

    Contact Us